A Multicenter, Randomized, Double-blind, Dose Escalation Trial to Compare the Effect of Oral Doses of Zafirlukast (ACCOLATE ) in Subjects with Mild to Moderate Asthma.

Study identifier:9188IL/0088

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicenter, Randomized, Double-blind, Dose Escalation Trial to Compare the Effect of Oral Doses of Zafirlukast (ACCOLATE ) in Subjects with Mild to Moderate Asthma.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jun 1995

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2048&filename=CSR-9188IL-0088.pdf
Download
CSR-9188IL-0088.pdf
Download
Trial Results Summaries
Available here

A Multicenter, Randomized, Double-blind, Dose Escalation Trial to Compare the Effect of Oral Doses of Zafirlukast (ACCOLATE ) in Subjects with Mild to Moderate Asthma.

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2048&filename=CSR-9188IL-0088.pdf

CSR-9188IL-0088.pdf

Trial Results Summaries